Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species
Science Advances · 2025
DOI: 10.1126/sciadv.adx9405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Debra S Yee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Virus Replication, Orthobunyavirus, Bunyaviridae Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
An Oropouche virus (OROV) outbreak occurred in South America in 2024. The pathogenic potential and host immunological response of this emerging virus are largely unknown, as animal models have been poorly explored. We infected nonhuman primate (NHP) species with OROV and followed viral replication dynamics and subsequent innate and adaptive immunological responses. OROV efficiently replicated in pigtail macaques, rhesus macaques, and vervet African green monkeys. OROV also replicated in sabeus African green monkey, albeit at lower levels than other hosts. OROV RNA was detected in plasma and nasal swabs and infection-induced high levels of innate inflammation, type I interferon gene signatures, immunoglobulin M–positive B cell expansion, high titers of neutralizing antibodies, and detectable frequencies of OROV-specific T cells. Prior infection was protective against reinfection up to 524 days post–initial infection, demonstrating possible protective immunity induction against OROV infection. These data suggest that multiple NHP species are appropriate models for OROV infection and the development of therapeutics and vaccinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
- Arbovirus Immunity Section, Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
- Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, NIAID, NIH, Hamilton, MT, USA.
- Integrated Data Sciences Section, Research Technologies Branch, NIAID, NIH, Bethesda, MD, USA.
ORCID-Profile: Debra S Yee, Jonathan P Davies, Laura A VanBlargan, Andrew R Rahmberg, Katherine E Burgomaster, Kelsie Brooks, Jacob K Flynn, Byron Shue, Alexandra M Ortiz, Paul Schaughency, Sonja M Best, Theodore C Pierson, Jason M Brenchley
Zitieren
APA
Yee, D. S., Davies, J. P., VanBlargan, L. A., Rahmberg, A. R., Burgomaster, K. E., Brooks, K., Flynn, J. K., Shue, B., Ortiz, A. M., Schaughency, P., Best, S. M., Pierson, T. C., & Brenchley, J. M. (2025). Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species. Science Advances. https://doi.org/10.1126/sciadv.adx9405
Vancouver
Yee DS, Davies JP, VanBlargan LA, Rahmberg AR, Burgomaster KE, Brooks K, et al. Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species. Science Advances. 2025. doi:10.1126/sciadv.adx9405
BibTeX
@article{Yee2025,
author = {Yee, Debra S and Davies, Jonathan P and VanBlargan, Laura A and Rahmberg, Andrew R and Burgomaster, Katherine E and Brooks, Kelsie and Flynn, Jacob K and Shue, Byron and Ortiz, Alexandra M and Schaughency, Paul and Best, Sonja M and Pierson, Theodore C and Brenchley, Jason M},
title = {Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx9405}
}
EUVIMED